Search details
1.
Exosomes in breast cancer management: Where do we stand? A literature review.
Biol Cell
; 114(4): 109-122, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35080041
2.
PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients
Medicina (Kaunas)
; 58(10)2022 Oct 06.
Article
in English
| MEDLINE | ID: mdl-36295559
3.
Trastuzumab administration during pregnancy: an update.
BMC Cancer
; 21(1): 463, 2021 04 26.
Article
in English
| MEDLINE | ID: mdl-33902516
4.
Germline mutations in a clinic-based series of pregnancy associated breast cancer patients.
BMC Cancer
; 21(1): 572, 2021 May 19.
Article
in English
| MEDLINE | ID: mdl-34011307
5.
Update Overview of the Role of Angiopoietins in Lung Cancer.
Medicina (Kaunas)
; 57(11)2021 Nov 01.
Article
in English
| MEDLINE | ID: mdl-34833409
6.
RANKL, OPG, TRAIL, KRas, and c-Fos expression in relation to central lymph node metastases in papillary thyroid carcinoma.
J BUON
; 23(4): 1029-1040, 2018.
Article
in English
| MEDLINE | ID: mdl-30358208
7.
Correction to: Trastuzumab administration during pregnancy: an update.
BMC Cancer
; 21(1): 1340, 2021 Dec 17.
Article
in English
| MEDLINE | ID: mdl-34920709
8.
Oral SERDs alone or in combination with CDK 4/6 inhibitors in breast cancer: Current perspectives and clinical trials.
Breast
; 75: 103729, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38599049
9.
The Immunohistochemical Expression of REV-7 in Various Human Cancer Pathology Specimens: A Systematic Review.
Cureus
; 16(1): e52542, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38371007
10.
Expression of DNA Repair Genes in Ewing Sarcoma.
Cancer Diagn Progn
; 4(3): 231-238, 2024.
Article
in English
| MEDLINE | ID: mdl-38707718
11.
Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins.
Int Urol Nephrol
; 56(6): 1887-1898, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38285100
12.
Prognostic Value of Circulating Tumor DNA (ctDNA) in Oncogene-Driven NSCLC: Current Knowledge and Future Perspectives.
Cancers (Basel)
; 14(19)2022 Oct 10.
Article
in English
| MEDLINE | ID: mdl-36230877
13.
MicroRNAs as therapeutic targets in breast cancer metastasis.
Drug Deliv Transl Res
; 12(5): 1029-1046, 2022 05.
Article
in English
| MEDLINE | ID: mdl-33987801
14.
Circulating miRNA Expression Profiling in Breast Cancer Molecular Subtypes: Applying Machine Learning Analysis in Bioinformatics.
Cancer Diagn Progn
; 2(6): 739-749, 2022.
Article
in English
| MEDLINE | ID: mdl-36340453
15.
High-throughput Proteomic Profiling of Male Breast Cancer Tissue.
Cancer Genomics Proteomics
; 19(2): 229-240, 2022.
Article
in English
| MEDLINE | ID: mdl-35181590
16.
Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.
Breast Care (Basel)
; 17(1): 63-70, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-35355696
17.
Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis.
Front Oncol
; 12: 1030786, 2022.
Article
in English
| MEDLINE | ID: mdl-36531003
18.
Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer.
Genes (Basel)
; 13(8)2022 07 29.
Article
in English
| MEDLINE | ID: mdl-36011273
19.
Baseline Ang-2 Serum Levels as a Predictive Factor for Survival in NSCLC and SCLC.
Life (Basel)
; 12(12)2022 Dec 13.
Article
in English
| MEDLINE | ID: mdl-36556457
20.
Chasing Hippos: Implications of YAP1 and TAZ Expression in Pregnancy-associated Breast Cancer Tumorigenesis.
In Vivo
; 36(6): 2869-2874, 2022.
Article
in English
| MEDLINE | ID: mdl-36309401